Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 18,700 | 11,512 | 14,343 | 9,831 | -21,116 |
| Operating Income | -18,700 | -11,512 | -14,343 | -9,831 | 21,116 |
| Other Income | 1,258 | -44 | 204 | 295 | -2,593 |
| Pre-tax Income | -17,442 | -11,556 | -14,139 | -9,536 | 18,523 |
| Net Income Continuous | -17,442 | -11,556 | -14,139 | -9,536 | 18,523 |
| Net Income | $-17,442 | $-11,556 | $-14,139 | $-9,536 | $18,523 |
| EPS Basic Total Ops | 96.46 | -36.55 | -44.82 | -30.37 | -106.23 |
| EPS Basic Continuous Ops | 96.46 | -36.55 | -44.82 | -30.37 | -106.24 |
| EPS Diluted Total Ops | 96.46 | -36.55 | -44.82 | -30.37 | -106.23 |
| EPS Diluted Continuous Ops | 96.46 | -36.55 | -44.82 | -30.37 | -106.24 |
| EPS Diluted Before Non-Recurring Items | -1.37 | -1.10 | -1.60 | N/A | N/A |
| EBITDA(a) | $-18,478 | $-11,230 | $-14,194 | $-9,680 | $25,101 |